Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amitick C Solution is a veterinary ectoparasiticide developed and marketed by Pure Med Farma (Pure Med Biotech). It is a combination product typically formulated for the control and treatment of external parasites such as ticks, mites, lice, and fleas in livestock (cattle, sheep, goats) and dogs. The solution contains two primary active ingredients: amitraz and cypermethrin. Amitraz is a formamidine acaricide and insecticide that acts as an agonist at octopamine receptors in the parasite's nervous system, leading to overexcitation and death. Cypermethrin is a synthetic pyrethroid that disrupts the nervous system by modulating voltage-gated sodium channels, preventing their closure and causing prolonged nerve impulses that result in paralysis. The product is intended for topical administration, often applied as a spray or dip.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amitraz + cypermethrin.